Related Experiment Videos
[Cellular immunity in pregnancy-induced hypertensive diseases]
H Schröcksnadel1, M Herold, G Steckel-Berger
1Universitätsklinik für Frauenheilkunde, Innsbruck.
Geburtshilfe Und Frauenheilkunde
|October 1, 1992
Summary
Hypertensive disorders of pregnancy are linked to elevated levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and neopterin. These findings suggest a role for cell-mediated immunity, particularly monocytes/macrophages, in the disease
Area of Science:
- Immunology and Pregnancy Research
- Biomarkers in Hypertensive Disorders
Context:
- Hypertensive disorders of pregnancy (HDP) are significant causes of maternal and fetal morbidity.
- Understanding the underlying pathophysiological mechanisms of HDP is crucial for improved management.
Purpose:
- To investigate serum cytokine profiles in patients with hypertensive disorders of pregnancy.
- To explore the potential role of immune system activation, specifically cell-mediated immunity, in HDP.
Summary:
- Serum levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and neopterin were significantly elevated in women with hypertensive disorders of pregnancy compared to healthy controls.
- While T-lymphocytic cytokines showed no significant differences, elevated IL-6, TNF-alpha, and neopterin (monocytic origin) were more pronounced in severe HDP forms, including HELLP syndrome.
- Positive correlations among IL-6, TNF-alpha, and neopterin suggest a shared monocytic pathway contributing to HDP pathogenesis.
Impact:
- These findings indicate that activated cell-mediated immunity, particularly involving monocytes/macrophages, plays a role in the pathophysiology of hypertensive disorders of pregnancy.
- Elevated IL-6, TNF-alpha, and neopterin may serve as potential biomarkers for HDP and its severity.